Emerging research suggest Retatru tide , a dual stimulator targeting both GLP-1 and glucose-dependent insulinotropic polypeptide , may offer a significant advancement for weight loss . Early clinical tests have demonstrated substantial decreases in abdominal fat , conceivably surpassing current obesity medications . Nevertheless , more evaluation i